Meridian™
Universe

REGN · CIK 0000872589 · FY2025 live · 2025-12-31

REGENERON PHARMACEUTICALS, INC.

SafeSEC 10-KClassic ZHealthcare89th percentile in Healthcare · 736 names

View as

Model

Classic Z

FY2025

4.30

Zone

Safe

Prior

—

Market DD

—

1y PD

—

4.30

Z″ 9.21

−21.83.08+

Score 4.30 · distress below 1.80, grey to 2.99, safe at 3.00 and above.

Classic Z factor contributions

  • X1 Working capital / assets

    Short-term liquidity versus the size of the balance sheet.

    0.34
    1.2 × = 0.40

  • X2 Retained earnings / assets

    Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.

    0.88
    1.4 × = 1.24

  • X3 EBIT / assets

    Operating return on assets. Highest weight in the original model.

    0.09
    3.3 × = 0.29

  • X4 Book equity / liabilities

    Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.

    3.36
    0.6 × = 2.02

  • X5 Sales / assets

    Asset turnover — how much revenue the asset base supports.

    0.35
    1 × = 0.35

Five-year path

Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.

Meridian Rank

91.45

0–100 · Classic Z family

  • Book standing

    89

  • Year change

    —

  • Market PD

    —

  • O-score

    98

Events on this name

Same published rows as Today.

  • Approaching grey

    watch · 41

    • Live score: — → 4.30
    • Cut: — → 1.80

Overview

rule-v1

REGENERON PHARMACEUTICALS, INC. is on classic Z at 4.30 (safe) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print; retained earnings / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers. Buybacks can send retained earnings negative at otherwise healthy issuers. X4 is book equity.

Book screen Safe; market PD —. Market PD has not been priced on this name.

Market DD · naive Merton

No market tape yet.

Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.

Sector peers

Closest Classic Z scores · 89th percentile in Healthcare.

Filing line items

Current assets

$18.0B

Total assets

$40.6B

Current liabilities

$4.4B

Total liabilities

$9.3B

Working capital

$13.7B

Retained earnings

$35.8B

EBIT

$3.6B

Total sales

$14.3B

Book equity

$31.3B

Accession 0000872589-26-000008. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.